| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,622 |
18,611 |
$1.09M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,962 |
5,240 |
$447K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,331 |
3,078 |
$276K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,263 |
3,069 |
$245K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,839 |
1,537 |
$138K |
| 90686 |
|
4,628 |
4,136 |
$47K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
440 |
429 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,153 |
926 |
$29K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,719 |
1,371 |
$27K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
274 |
262 |
$21K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
267 |
161 |
$18K |
| 90670 |
|
1,520 |
1,139 |
$15K |
| 90651 |
|
1,231 |
1,043 |
$14K |
| 90734 |
|
1,242 |
1,063 |
$13K |
| 90620 |
|
893 |
723 |
$10K |
| 90707 |
|
775 |
611 |
$8K |
| 90716 |
|
785 |
641 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
273 |
261 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
274 |
262 |
$6K |
| 90633 |
|
741 |
599 |
$6K |
| 90715 |
|
488 |
416 |
$5K |
| 90680 |
|
280 |
211 |
$2K |
| 90648 |
|
262 |
209 |
$2K |
| 90698 |
|
226 |
172 |
$2K |
| 90677 |
|
79 |
59 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
24 |
$811.44 |
| 99000 |
|
35 |
35 |
$793.42 |
| 90696 |
|
102 |
89 |
$783.49 |
| 90685 |
|
104 |
83 |
$702.40 |
| 90744 |
|
17 |
13 |
$108.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
35 |
27 |
$0.00 |